|
CN105311043A
|
|
Application of compositions to prepare medicines treating dermotosis of metabolism disturbance
|
|
CN105267228A
|
|
Application of pharmaceutical compositions in preparation of drugs for treating neuropsychic disturbance dermatosis
|
|
CN105311024A
|
|
Application of oxymatrine and derivatives to prepare medicines treating skin vasculitis
|
|
CN105311044A
|
|
Application of pharmaceutical composition to prepare medicines treating cutaneous vasculitis
|
|
CN105287538A
|
|
Kushenin and application of kushenin derivatives to preparation of medicine for treating lichen planus
|
|
CN105311025A
|
|
Application of oxymatrine and derivatives to prepare medicines treating aseptic pustular dermatosis
|
|
CN105311023A
|
|
Application of oxymatrine and derivatives thereof to prepare medicines treating skin lymphoid hyperplasia related diseases
|
|
CN105267227A
|
|
Application of pharmaceutical compositions in preparation of drugs for treating sterile pustular dermatosis
|
|
CN104161763A
|
|
Application of pharmaceutical compositions in treatment of eczematous dermatitis
|
|
CN104161764A
|
|
Application of pharmaceutical compositions containing kushenin and glycyrrhizic acid in treatment of psoriasis
|
|
CN102973560A
|
|
Novel method of applying matrine to treating eczematous dermatitis
|
|
CN102973559A
|
|
Novel method of applying oxymatrine to treating eczematous dermatitis
|
|
CN102772406A
|
|
Novel application method of treating psoriasis by oxymatrine
|
